Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Randomized Controlled Trial to Evaluate the Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan

NCT03183375 is registered in ClinicalTrials.gov with Dr.Saqib Hussain Ansari as lead sponsor.

NCT NCT03183375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Randomized Controlled Trial to Evaluate the Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan
Lead sponsor
Dr.Saqib Hussain Ansari
Phase
Phase 2
Overall status
Unknown status
Start date
August 21, 2017
Completion date
June 30, 2018
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia, beta